Lucid Diagnostics
LUCD
49 hedge funds and large institutions have $14.1M invested in Lucid Diagnostics in 2025 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 4 closing their positions.
403% more capital invested
Capital invested by funds: $2.8M → $14.1M (+$11.3M)
400% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 4
50% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 8
48% more funds holding
Funds holding: 33 → 49 (+16)
5.23% more ownership
Funds ownership: 5.58% → 10.81% (+5.2%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
+$3.27M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.27M |
| 3 |
Renaissance Technologies
New York
|
+$551K |
| 4 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
+$506K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$394K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LM
Luminus Management
Houston,
Texas
|
-$672K |
| 2 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
-$598K |
| 3 |
HF
HRT Financial
New York
|
-$52K |
| 4 |
LPL Financial
San Diego,
California
|
-$27.9K |
| 5 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
-$24.2K |
LUCD Hedge Fund Activity: Q1 2025 in Review
49 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q1 2025, worth a combined $14.1M — up 403% from $2.8M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new LUCD positions and 4 closed out — a net gain of 16 holders — while 12 added to existing stakes and 8 trimmed.
The largest buyer was Masters Capital Management, opening a new position worth an estimated $3.27M. The largest seller was Luminus Management, cutting an estimated $672K.
- 49 institutional investors held Lucid Diagnostics (LUCD) as of Q1 2025, up from 33 in Q4 2024.
- Funds reported $14.1M of Lucid Diagnostics stock for Q1 2025, up 403% quarter-over-quarter.
- 20 funds opened new Lucid Diagnostics positions in Q1 2025 and 4 closed out, a net change of +16 holders.
- The largest Lucid Diagnostics buyer in Q1 2025 was Masters Capital Management, an estimated $3.27M added.
- The largest Lucid Diagnostics seller in Q1 2025 was Luminus Management, an estimated $672K sold.
Based on aggregated 13F filings for Q1 2025.